Skip to main content

Epidemiology, Transmission, and Molecular Immunopathology of SARS-CoV-2

  • Chapter
  • First Online:
Coronavirus Therapeutics – Volume I

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

2019-nCoV:

2019-novel coronavirus

ACE2:

Angiotensin-converting enzyme 2

ARDS:

Acute respiratory distress syndrome

COVID-19:

Coronavirus disease 2019

E:

Envelope protein

FAO:

Food and Agriculture Organization of the United Nations

HLA:

Human leukocyte antigen

IFN:

Interferon

IRF:

Interferon regulatory transcription factor

M:

Membrane protein

MERS-CoV:

Middle East respiratory syndrome-related coronavirus

MHC:

Major histocompatibility complex

N:

Nucleocapsid protein

NK:

Natural killer

NLRP:

NOD-like receptor

NSP:

Nonstructural protein

OIE:

World Organisation for Animal Health

ORF:

Open reading frame

PI(3,5)P2:

Phosphatidylinositol-3,5-bisphosphate

RBD:

Receptor binding domain

RIG-I:

Retinoic acid-inducible gene I

RLR:

RIG-I-like receptor

S:

Spike protein

SARS-CoV:

Severe acute respiratory syndrome-related coronavirus

SARS-CoV-2:

Severe acute respiratory syndrome-related coronavirus 2

TLR:

Toll-like receptor

TPC2:

Two pore channel subtype 2

WHO:

World Health Organization

References

Download references

Acknowledgments

This study was supported in part by the Faculty of Medicine, University of Oslo.

Conflict of Interest

The authors report no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Asim K. Duttaroy .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mallick, R., Duttaroy, A.K. (2021). Epidemiology, Transmission, and Molecular Immunopathology of SARS-CoV-2. In: Asea, A.A.A., Kaur, P. (eds) Coronavirus Therapeutics – Volume I. Advances in Experimental Medicine and Biology, vol 1352. Springer, Cham. https://doi.org/10.1007/978-3-030-85109-5_3

Download citation

Publish with us

Policies and ethics